UI Pathology Offers First "Next Generation Sequencing" Test for Customized Cancer Care

November 12, 2013

[[{"fid":"2121","view_mode":"full","attributes":{"alt":"Molecular Pathology Faculty and Staff","height":"220","width":"363","class":"media-element file-full"},"fields":{"format":"full","field_file_image_alt_text[und][0][value]":"Molecular Pathology Faculty and Staff","field_file_image_title_text[und][0][value]":""},"type":"media"}]]

Starting on October 24, the University of Iowa Department of Pathology implemented a new DNA sequencing test for Cancer Mutation Profiling and Interpretation. This is the first clinically validated massively parallel ('next generation') DNA sequencing test for cancer to be offered in Iowa.